Your browser doesn't support javascript.
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study.
Fallerini, Chiara; Daga, Sergio; Mantovani, Stefania; Benetti, Elisa; Picchiotti, Nicola; Francisci, Daniela; Paciosi, Francesco; Schiaroli, Elisabetta; Baldassarri, Margherita; Fava, Francesca; Palmieri, Maria; Ludovisi, Serena; Castelli, Francesco; Quiros-Roldan, Eugenia; Vaghi, Massimo; Rusconi, Stefano; Siano, Matteo; Bandini, Maria; Spiga, Ottavia; Capitani, Katia; Furini, Simone; Mari, Francesca; Renieri, Alessandra; Mondelli, Mario U; Frullanti, Elisa.
  • Fallerini C; Medical Genetics, University of Siena, Siena, Italy.
  • Daga S; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Mantovani S; Medical Genetics, University of Siena, Siena, Italy.
  • Benetti E; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Picchiotti N; Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Francisci D; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Paciosi F; Department of Mathematics, University of Pavia, Pavia, Italy.
  • Schiaroli E; University of Siena, DIISM-SAILAB, Siena, Italy.
  • Baldassarri M; Infectious Diseases Clinic, Department of Medicine 2, Azienda Ospedaliera di Perugia and University of Perugia, Santa Maria Hospital, Perugia, Italy.
  • Fava F; Infectious Diseases Clinic, "Santa Maria" Hospital, University of Perugia, Perugia, Italy.
  • Palmieri M; Infectious Diseases Clinic, Department of Medicine 2, Azienda Ospedaliera di Perugia and University of Perugia, Santa Maria Hospital, Perugia, Italy.
  • Ludovisi S; Infectious Diseases Clinic, "Santa Maria" Hospital, University of Perugia, Perugia, Italy.
  • Castelli F; Infectious Diseases Clinic, Department of Medicine 2, Azienda Ospedaliera di Perugia and University of Perugia, Santa Maria Hospital, Perugia, Italy.
  • Quiros-Roldan E; Medical Genetics, University of Siena, Siena, Italy.
  • Vaghi M; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Rusconi S; Medical Genetics, University of Siena, Siena, Italy.
  • Siano M; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Bandini M; Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
  • Spiga O; Medical Genetics, University of Siena, Siena, Italy.
  • Capitani K; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Furini S; Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Mari F; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
  • Renieri A; Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili Hospital, Brescia, Italy.
  • Mondelli MU; Chirurgia Vascolare, Ospedale Maggiore di Crema, Crema, Italy.
  • Frullanti E; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
Elife ; 102021 03 02.
Article in English | MEDLINE | ID: covidwho-1112866
ABSTRACT

Background:

Recently, loss-of-function variants in TLR7 were identified in two families in which COVID-19 segregates like an X-linked recessive disorder environmentally conditioned by SARS-CoV-2. We investigated whether the two families represent the tip of the iceberg of a subset of COVID-19 male patients.

Methods:

This is a nested case-control study in which we compared male participants with extreme phenotype selected from the Italian GEN-COVID cohort of SARS-CoV-2-infected participants (<60 y, 79 severe cases versus 77 control cases). We applied the LASSO Logistic Regression analysis, considering only rare variants on young male subsets with extreme phenotype, picking up TLR7 as the most important susceptibility gene.

Results:

Overall, we found TLR7 deleterious variants in 2.1% of severely affected males and in none of the asymptomatic participants. The functional gene expression profile analysis demonstrated a reduction in TLR7-related gene expression in patients compared with controls demonstrating an impairment in type I and II IFN responses.

Conclusions:

Young males with TLR7 loss-of-function variants and severe COVID-19 represent a subset of male patients contributing to disease susceptibility in up to 2% of severe COVID-19.

Funding:

Funded by private donors for the Host Genetics Research Project, the Intesa San Paolo for 2020 charity fund, and the Host Genetics Initiative. Clinical trial number NCT04549831.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Polymorphism, Single Nucleotide / Toll-Like Receptor 7 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Adult / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: ELife.67569

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Polymorphism, Single Nucleotide / Toll-Like Receptor 7 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Adult / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: ELife.67569